AI Reputation Analysis and Signal Evaluation – ILUVIEN (Alimera Sciences, Inc.)

B
Reputation Level
Unclear / Mixed / Unclassifiable Industry
41.2 Avg Reputation

Based on 2387 businesses audited.

Brand AI Reputation

Unclear / Mixed / Unclassifiable Industry Reputation: ILUVIEN (Alimera Sciences, Inc.) (iluvien.com)

https://iluvien.com 📍 Industry: Unclear / Mixed / Unclassifiable Industry
72 Reputation / 100

This is a low-BS, regulation-heavy pharmaceutical brochure that prioritizes legal compliance over narrative persuasion. While the schema-based review counts are a minor deceptive flag, the technical specificity of the drug data provides significant substance.

Info Density Power-words vs. Substance ratio.
20 67% Reputation
View evidence →
Semantic Coherence Homepage promise vs. Sub-page reality.
19 95% Reputation
View evidence →
Trust & Proof Verifiable evidence vs. Trust Theatre.
8 40% Reputation
View evidence →
Commodity Fingerprint Detection of industry clichés/templates.
13 87% Reputation
View evidence →
Identity & Authority Expert verifiability & Schema depth.
12 80% Reputation
View evidence →

Unclear / Mixed / Unclassifiable Industry Reputation: ILUVIEN (Alimera Sciences, Inc.) (iluvien.com)

Reputation: 72 / 100

The site perfectly matches the Pharmaceutical and Healthcare industry category, specifically focusing on ophthalmic biotechnology for Diabetic Macular Edema (DME). The content is dominated by regulatory requirements, clinical indications, and safety protocols typical of FDA-regulated medical products.

“The score of 72 is primarily driven by Trust Theatre (8 points) and high Concept Repetition (5 points). The site is largely free of industry jargon and semantic drift, but the empty H1 and technical hierarchy issues in the headings added to the Information Density penalty. The high substance of the medical claims kept the score well below the 'High BS' threshold.”

Verified Analysis Date: May 27, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result